insights_auto
Why is ALMKT down 3,38%?
Dive Deeperchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,12 €
arrow_downward
-3,38%(-0,0042) 1D
5 հոկ, 17:35:04 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
0,13 €
High
0,13 €
Low
0,12 €
Mkt. cap
24,25 մլն
Avg. vol.
440,14 հզր
Volume
560,78 հզր
P/E ratio
0,98
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 մլն
No. of employees
59
Open
0,13 €
High
0,13 €
Low
0,12 €
Mkt. cap
24,25 մլն
Avg. vol.
440,14 հզր
Volume
560,78 հզր
P/E ratio
0,98
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 մլն
No. of employees
59
News stories
From web sources and news partners
Carroll County Mirror-Democrat
·
53 րոպե առաջ
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq
Yahoo Finance
·
25 րոպե առաջ
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns
The Business Journals
·
47 րոպե առաջ
Georgia Banking Co. plans to go public as it sees a void in the market amid industry consolidation
Morningstar
·
1 ժամ առաջ
Trade Gap Expected to Widen — Data Week Ahead Update
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA